UBS Group’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.86M Buy
570,148
+193,772
+51% +$2.92M ﹤0.01% 3612
2025
Q4
$6.79M Buy
376,376
+187,220
+99% +$3.36M ﹤0.01% 3711
2025
Q3
$3.51M Sell
189,156
-239,622
-56% -$3.76M ﹤0.01% 4408
2025
Q2
$6.86M Sell
428,778
-309,968
-42% -$5.53M ﹤0.01% 3531
2025
Q1
$14.4M Buy
738,746
+244,570
+49% +$5.15M ﹤0.01% 2667
2024
Q4
$10.9M Buy
494,176
+128,956
+35% +$2.48M ﹤0.01% 2945
2024
Q3
$6.15M Buy
365,220
+9,903
+3% +$147K ﹤0.01% 2860
2024
Q2
$4.25M Buy
355,317
+145,144
+69% +$1.62M ﹤0.01% 3027
2024
Q1
$2.33M Buy
210,173
+121,945
+138% +$1.24M ﹤0.01% 3788
2023
Q4
$764K Buy
88,228
+50,401
+133% +$392K ﹤0.01% 4733
2023
Q3
$289K Buy
37,827
+31,595
+507% +$237K ﹤0.01% 5081
2023
Q2
$44.9K Buy
6,232
+1,929
+45% +$11.2K ﹤0.01% 6534
2023
Q1
$26.2K Buy
+4,303
New +$23.3K ﹤0.01% 6885
2022
Q1
Sell
-2,865
Closed -$23K 10311
2021
Q4
$23K Sell
2,865
-1,885
-40% -$17.8K ﹤0.01% 7671
2021
Q3
$44K Buy
+4,750
New +$49.6K ﹤0.01% 6435

Other funds holding CLBT